Glen Santangelo
Stock Analyst at Jefferies
(2.62)
# 2,262
Out of 5,044 analysts
78
Total ratings
50%
Success rate
3.55%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $130 → $134 | $95.15 | +40.83% | 6 | Sep 3, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $8.36 | -4.31% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $93.34 | -14.29% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.29 | +26.34% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $39.49 | +29.15% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $9.23 | -34.99% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.06 | +9.67% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $13.07 | +53.02% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $21.36 | -15.73% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $19.23 | +24.80% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $23 | $47.12 | -51.19% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $19.78 | +16.28% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $35.41 | +24.26% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $22.12 | -23.15% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $145.41 | +58.17% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $3.62 | +2,662.43% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $24.18 | +189.50% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $36.85 | +49.25% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $13.54 | +18.17% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $66.48 | -30.81% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $3.38 | +728.40% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.41 | +199.02% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $5.34 | +2,147.19% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.70 | -25.93% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $3.66 | +1,184.15% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $2.94 | +1,124.49% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $82.20 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $804.59 | -79.00% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $162.79 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $63.21 | +29.73% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $133.14 | +87.77% | 1 | Dec 8, 2017 |
HealthEquity
Sep 3, 2025
Maintains: Buy
Price Target: $130 → $134
Current: $95.15
Upside: +40.83%
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $8.36
Upside: -4.31%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $93.34
Upside: -14.29%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.29
Upside: +26.34%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $39.49
Upside: +29.15%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $9.23
Upside: -34.99%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.06
Upside: +9.67%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $13.07
Upside: +53.02%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $21.36
Upside: -15.73%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $19.23
Upside: +24.80%
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $47.12
Upside: -51.19%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $19.78
Upside: +16.28%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $35.41
Upside: +24.26%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $22.12
Upside: -23.15%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $145.41
Upside: +58.17%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $3.62
Upside: +2,662.43%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $24.18
Upside: +189.50%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $36.85
Upside: +49.25%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $13.54
Upside: +18.17%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $66.48
Upside: -30.81%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $3.38
Upside: +728.40%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $23.41
Upside: +199.02%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $5.34
Upside: +2,147.19%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.70
Upside: -25.93%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $3.66
Upside: +1,184.15%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $2.94
Upside: +1,124.49%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $82.20
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $804.59
Upside: -79.00%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $162.79
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $63.21
Upside: +29.73%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $133.14
Upside: +87.77%